Molina Healthcare (MOH) EBITDA (2010 - 2026)

Molina Healthcare has disclosed EBITDA across 17 years of filings, most recently posting $145.0 million for Q2 2026.

• In Q2 2026, EBITDA fell 61.13% year-over-year to $145.0 million; the TTM figure through Jun 2026 stood at $218.0 million (down 86.81% YoY), while the FY2025 annual figure was $788.0 million, down 54.27% from the prior year.
• EBITDA came in at $145.0 million for Q2 2026 at Molina Healthcare, up from $98.0 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of $1.1 billion in Q3 2022 to a low of -$162.0 million in Q4 2025.
• Average EBITDA over 5 years is $381.0 million, with a median of $380.0 million recorded in 2024.
• Year-over-year, EBITDA jumped 383.26% in 2022 and tumbled 142.63% in 2025.
• Over 5 years, EBITDA stood at $1.1 billion in 2022, then tumbled by 70.41% to $316.0 million in 2023, then increased by 20.25% to $380.0 million in 2024, then plunged by 142.63% to -$162.0 million in 2025, then soared by 189.51% to $145.0 million in 2026.
• Per Business Quant data, the three most recent EBITDA figures were $145.0 million in Q2 2026, $98.0 million in Q1 2026, and -$162.0 million in Q4 2025.